BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37142543)

  • 1. Beyond current treatment of Fanconi Anemia: What do advances in cell and gene-based approaches offer?
    Martínez-Balsalobre E; Guervilly JH; van Asbeck-van der Wijst J; Pérez-Oliva AB; Lachaud C
    Blood Rev; 2023 Jul; 60():101094. PubMed ID: 37142543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia.
    Román-Rodríguez FJ; Ugalde L; Álvarez L; Díez B; Ramírez MJ; Risueño C; Cortón M; Bogliolo M; Bernal S; March F; Ayuso C; Hanenberg H; Sevilla J; Rodríguez-Perales S; Torres-Ruiz R; Surrallés J; Bueren JA; Río P
    Cell Stem Cell; 2019 Nov; 25(5):607-621.e7. PubMed ID: 31543367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Gene Therapy for Fanconi Anemia.
    Río P; Navarro S; Bueren JA
    Hum Gene Ther; 2018 Oct; 29(10):1114-1123. PubMed ID: 30117331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
    Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
    Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics.
    Bogliolo M; Surrallés J
    Curr Opin Genet Dev; 2015 Aug; 33():32-40. PubMed ID: 26254775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
    Hanenberg H; Roellecke K; Wiek C
    Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia.
    Adair JE; Sevilla J; Heredia CD; Becker PS; Kiem HP; Bueren J
    Curr Gene Ther; 2017; 16(5):338-348. PubMed ID: 28103787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fanconi Anemia: A DNA repair disorder characterized by accelerated decline of the hematopoietic stem cell compartment and other features of aging.
    Brosh RM; Bellani M; Liu Y; Seidman MM
    Ageing Res Rev; 2017 Jan; 33():67-75. PubMed ID: 27223997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia.
    Río P; Navarro S; Wang W; Sánchez-Domínguez R; Pujol RM; Segovia JC; Bogliolo M; Merino E; Wu N; Salgado R; Lamana ML; Yañez RM; Casado JA; Giménez Y; Román-Rodríguez FJ; Álvarez L; Alberquilla O; Raimbault A; Guenechea G; Lozano ML; Cerrato L; Hernando M; Gálvez E; Hladun R; Giralt I; Barquinero J; Galy A; García de Andoín N; López R; Catalá A; Schwartz JD; Surrallés J; Soulier J; Schmidt M; Díaz de Heredia C; Sevilla J; Bueren JA
    Nat Med; 2019 Sep; 25(9):1396-1401. PubMed ID: 31501599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenine base editing efficiently restores the function of Fanconi anemia hematopoietic stem and progenitor cells.
    Siegner SM; Ugalde L; Clemens A; Garcia-Garcia L; Bueren JA; Rio P; Karasu ME; Corn JE
    Nat Commun; 2022 Nov; 13(1):6900. PubMed ID: 36371486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.
    Nicoletti E; Rao G; Bueren JA; Río P; Navarro S; Surrallés J; Choi G; Schwartz JD
    Ann Hematol; 2020 May; 99(5):913-924. PubMed ID: 32065290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair.
    van de Vrugt HJ; Harmsen T; Riepsaame J; Alexantya G; van Mil SE; de Vries Y; Bin Ali R; Huijbers IJ; Dorsman JC; Wolthuis RMF; Te Riele H
    Sci Rep; 2019 Jan; 9(1):768. PubMed ID: 30683899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy.
    Navarro S; Moleiro V; Molina-Estevez FJ; Lozano ML; Chinchon R; Almarza E; Quintana-Bustamante O; Mostoslavsky G; Maetzig T; Galla M; Heinz N; Schiedlmeier B; Torres Y; Modlich U; Samper E; Río P; Segovia JC; Raya A; Güenechea G; Izpisua-Belmonte JC; Bueren JA
    Stem Cells; 2014 Feb; 32(2):436-46. PubMed ID: 24420904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.
    Ceccaldi R; Parmar K; Mouly E; Delord M; Kim JM; Regairaz M; Pla M; Vasquez N; Zhang QS; Pondarre C; Peffault de Latour R; Gluckman E; Cavazzana-Calvo M; Leblanc T; Larghero J; Grompe M; Socié G; D'Andrea AD; Soulier J
    Cell Stem Cell; 2012 Jul; 11(1):36-49. PubMed ID: 22683204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic correction of Fanconi anemia cells in the murine bone marrow after carrier cell mediated delivery of lentiviral vector.
    Chakkaramakkil Verghese S; Goloviznina NA; Kurre P
    Stem Cell Res Ther; 2016 Nov; 7(1):170. PubMed ID: 27865213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief report: human pluripotent stem cell models of fanconi anemia deficiency reveal an important role for fanconi anemia proteins in cellular reprogramming and survival of hematopoietic progenitors.
    Yung SK; Tilgner K; Ledran MH; Habibollah S; Neganova I; Singhapol C; Saretzki G; Stojkovic M; Armstrong L; Przyborski S; Lako M
    Stem Cells; 2013 May; 31(5):1022-9. PubMed ID: 23280624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal conditioning in Fanconi anemia promotes multi-lineage marrow engraftment at 10-fold lower cell doses.
    Haworth KG; Ironside C; Ramirez MA; Weitz S; Beard BC; Schwartz JD; Adair JE; Kiem HP
    J Gene Med; 2018 Oct; 20(10-11):e3050. PubMed ID: 30129972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations.
    Ebens CL; MacMillan ML; Wagner JE
    Expert Rev Hematol; 2017 Jan; 10(1):81-97. PubMed ID: 27929686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pluripotent cell models of fanconi anemia identify the early pathological defect in human hemoangiogenic progenitors.
    Suzuki NM; Niwa A; Yabe M; Hira A; Okada C; Amano N; Watanabe A; Watanabe K; Heike T; Takata M; Nakahata T; Saito MK
    Stem Cells Transl Med; 2015 Apr; 4(4):333-8. PubMed ID: 25762002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fanconi anemia.
    Green AM; Kupfer GM
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):193-214. PubMed ID: 19327579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.